The new variants of SARS-CoV-2

UK variant of SARS-CoV-2

Mutations of SARS-CoV-2

The new variants of SARS-CoV-2

In December 2020 new SARS-CoV-2 variants were detected in the United Kingdom and South Africa. The UK SARS-CoV-2 variant is called B.1.17 (VUI 202012/01), the South African Variant is called B.1.351 and both are characterized by multiple mutations in the spike protein of the SARS-CoV-2 virus. The mutations in the spike protein of the variant leads to false negative results when using RT-PCR assays targeting the S-gene. All PerkinElmer SARS-CoV-2 RT-PCR assays are designed to identify SARS-CoV-2 ORF1ab and N genes, therefore the B.1.1.7 and B.1.351 variants do not affect the detection of SARS-CoV-2 by PerkinElmer RT-PCR assays.

Saliva for SARS-CoV-2 testing

Saliva for SARS-CoV-2 testing

Saliva as alternative sample material

Saliva for SARS-CoV-2 testing

Do you already know that saliva can be used as alternative sample material for SARS-CoV-2 testing? Read this interesting publication to learn how to use the chemagic™ Viral DNA/RNA 300 Kit H96 on the chemagic™ 360 instrument with saliva.

For research use only. Not for use in diagnostic procedures.

High-throughput explorer Workstations

chemagic 360 instruments in explorer G3 workstations

End-to-End High-throughput workstations

End-to-End High-throughput explorer™ G3 Workstations

Do you already know that our chemagic™ 360 instrument can also be integrated in fully automated explorer™ G3 workstations? The explorer™ G3 workstations enable a SARS-CoV-2 testing capacity of up to 10,000 samples/day. This week the first explorer™ G3 workstations were installed and validated at customers and will now start with the SARS-CoV-2 testing.

For research use only. Not for use in diagnostic procedures.

chemagic 360 instruments in Antwerpen

chemagic 360 instruments in Antwerpen

chemagic™ 360 instruments in Antwerpen

chemagic™ 360 instruments in Belgium

Take a look at this clinical lab in Antwerpen! These four chemagic™ 360 instruments enable a Covid-19 testing capacity of up to 4000 samples/day for 7 days a week. They are part of the PerkinElmer SARS-CoV- 2 testing solution in a clinical lab in Belgium!

For research use only. Not for use in diagnostic procedures.

European Biobank Week 2020

PerkinElmer at Europe Biobank Week 2020

EBW 2020

Meet us at Europe Biobank Week 2020!

We are happy to join the European Biobank Week 2020 Conference from November 17-20 this week. Meet us on our virtual booth and talk with our experts about improving your biobanking efficiency.

 

New Technical Note cfDNA purification

Technical Note about cfDNA extraction with chemagic kits

New Technical Note cfDNA extraction

New Technical Note about high-throughput cfDNA isolation from plasma

PerkinElmer chemagen has developed the chemagic cfDNA Kits which enable the automated and efficient extraction of circulating cell-free DNA from 0.5 - 5 ml plasma in 24-well or 96-well format in maximal 2 hours with minimal hands-on time. Furthermore, the kits show equivalent yields as well as purities compared to a manual silica-spin based kit.

CE-IVD marked SARS-CoV-2 Real-Time RT-PCR

CE-IVD mark update for the PerkinElmer SARS-CoV-2 Real-time RT-PCR assay

CE-IVD mark update for SARS-CoV-2 RT-PCR assay

CE-IVD Mark Update for PerkinElmer® SARS-CoV-2 Real-Time RT-PCR Assay

The range of sample materials was upgraded, therefore the CE-IVD marked PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay can be used for oropharyngeal, nasopharyngeal swabs and now for saliva samples as well. In addition, it is now possible to perform the SARS-CoV-2 detection with pooled samples of up to 5 individuals showing an acute Covid-19 infection as well as asymptomatic carriers.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Pooled samples for SARS-CoV-2 testing

Pooled samples for SARS-CoV-2 testing

FDA Emergency Use Authorization for Sample Pooling

FDA Emergency Use Authorization for Sample Pooling

PerkinElmer received the FDA EUA authorization to detect SARS-CoV-2 pathogen RNA in pooled samples containing multiple individual respiratory swabs. Furthermore, the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit allows sample pooling on multiple RT-PCR platforms. While other RT-PCR kit manufacturers struggle with accurate detection due to lack of sensitivity, the PerkinElmer kit convinces by the lowest limit of detection.

For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.

ASHG 2020 Virtual Meeting

PerkinElmer at ASHG 2020 Virtual Meeting

ASHG Virtual Meeting 2020

Meet us at ASHG Virtual Meeting 2020!

The American Society of Human Genetics gets together in a virtual meeting from October 27th October 30th this year. Learn more about the PerkinElmer workflow solutions for human genetics and meet us on our virtual booth!

Respiratory SARS-CoV-2 Flu RT-PCR Panel

SARS flu respiratory testing panel

CE-IVD mark for simultaneous Covid-19 and flu test

The PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel assay is a real-time RT-PCR multiplexed test intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV. This workflow enables laboratories to conserve resources while testing a single sample for multiple pathogens.

The PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel assay is CE-IVD marked and intended for in vitro diagnostic use in Europe.